2165933-01-5 Usage
Uses
Used in Organic Synthesis:
(1S,2R)-methyl 2-(2-hydroxyethyl)cyclopropanecarboxylate is utilized as a building block in organic synthesis for the creation of various compounds. Its cyclopropane ring and functional groups make it a versatile component in constructing complex organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, (1S,2R)-methyl 2-(2-hydroxyethyl)cyclopropanecarboxylate serves as a key intermediate in the synthesis of potential drug candidates. Its unique stereochemistry and reactive sites can be leveraged to develop new medications with specific therapeutic targets.
Used in Drug Development:
(1S,2R)-methyl 2-(2-hydroxyethyl)cyclopropanecarboxylate may have applications in drug development due to its potential to be incorporated into novel molecular structures with biological activity. Its chiral nature allows for the exploration of enantioselective synthesis, which can lead to more effective and selective drugs.
Used in Medicinal Chemistry:
In medicinal chemistry, (1S,2R)-methyl 2-(2-hydroxyethyl)cyclopropanecarboxylate is employed for the design and synthesis of molecules with potential therapeutic properties. Its structural features can be exploited to create compounds that interact with biological targets, offering new avenues for treatment of various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 2165933-01-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,1,6,5,9,3 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2165933-01:
(9*2)+(8*1)+(7*6)+(6*5)+(5*9)+(4*3)+(3*3)+(2*0)+(1*1)=165
165 % 10 = 5
So 2165933-01-5 is a valid CAS Registry Number.
2165933-01-5Relevant academic research and scientific papers
BENZO[B]FURANS AS BROMODOMAIN INHIBITORS
-
Page/Page column 91; 92, (2017/11/06)
The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS
-
Page/Page column 136; 137, (2017/03/21)
The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
